Skip to main content
Clinical Trials/TCTR20230927001
TCTR20230927001
Recruiting
Phase 3

The feasibility of blood flow-restricted resistance exercise in individuals with chronic heart failure

one0 sites50 target enrollmentSeptember 27, 2023

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Patients with chronic heart failure
Sponsor
one
Enrollment
50
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 27, 2023
End Date
September 30, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
one

Eligibility Criteria

Inclusion Criteria

  • Patients with chronic HF under stable clinical condition, aged over 20, can follow instructions without mental illness or hearing impairment.

Exclusion Criteria

  • 1\. Have resistance training within the past six months.
  • 2\. Unable to perform squats due to degenerative joint arthritis.
  • 3\. Walk less than 30 minutes daily.
  • 4\. Have a history of venous thrombosis.
  • 5\. Peripheral neuropathy.
  • 6\. Severe peripheral arterial disease.
  • 7\. Impaired kidney function.
  • 8\. Severe hypertension.
  • 9\. Under dual antiplatelet therapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials